ClinicalTrials.gg
Sign In

Penile Neoplasms clinical trials

The registry lists 99 studies for Penile Neoplasms across more than 10 countries. 28 are recruiting or about to start. 38 of them are mainly about Penile Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Penile Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Recruiting
23
Active, not recruiting
12
Status unknown
5
Terminated
5
Not yet recruiting
4

Phase

Phase 2
44
Phase 1
25
Phase 3
3

Where

United States
45
China
16
United Kingdom
7
Netherlands
7
France
6
Canada
4

Who runs them

National Cancer Institute (NCI) (9) · M.D. Anderson Cancer Center (5) · Sun Yat-sen University (4) · The Netherlands Cancer Institute (4) · UNICANCER (3) · Fudan University (3) · The Affiliated Hospital of Qingdao University (2) · University of Maryland, College Park (2)

What is being tested here

Drugs under test in Penile Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pucotenlimab404
Becotatug vedotin404
Therapeutic Tumor Infiltrating Lymphocytes202
Nivolumab105
Pembrolizumab105
Ipilimumab103
Cabozantinib102
Sacituzumab tirumotecan101
Cemiplimab101
Enfortumab vedotin101

Drug classes tested here Immune checkpoint inhibitors 9 open · Tyrosine kinase inhibitors (TKIs) 2 open · Antimitotic agents 6 · Alkylating agents 5

Coming up

2phase 3 studies under way
14studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 23 Penile Neoplasms studies recruiting now, 18 (78%) set no upper age limit and 2 (9%) stop at 75 or younger. 2 (9%) take children under 18. 0 (0%) are for women only and 9 (39%) for men only; 2 (9%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
100 (0%)2 (9%)
1813 (57%)22 (96%)
3014 (61%)23 (100%)
4014 (61%)23 (100%)
5014 (61%)23 (100%)
6514 (61%)23 (100%)
7513 (57%)22 (96%)
8511 (48%)19 (83%)

Across all 99 studies, recruiting or not: 15% stop at 75 or younger and 4% at 65; 12% take children; 2% are for women only and 39% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Penile Neoplasms studies take

Of 28 phase 2 interventional studies under Penile Neoplasms, half reached primary completion within 63 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 263 mo35–… · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 99. Browse all 99 → or search them.